Emeritus ProfessorKimFox

Bousser M-G, Amarenco P, Chamorro A, Fisher M, Ford I, Fox KM, Hennerici MG, Mattle HP, Rothwell PM, de Cordouee A, Fratacci M-Det al., 2011, Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial, LANCET, Vol: 377, Pages: 2013-2022, ISSN: 0140-6736

• Author Web Link
• Cite
• Citations: 153

Tendera M, Talajic M, Robertson M, Tardif J-C, Ferrari R, Ford I, Steg PG, Fox Ket al., 2011, Safety of <i>Ivabradine</i> in Patients With Coronary Artery Disease and Left Ventricular Systolic Dysfunction (from the BEAUTIFUL Hotter Substudy), AMERICAN JOURNAL OF CARDIOLOGY, Vol: 107, Pages: 805-811, ISSN: 0002-9149

• Author Web Link
• Cite
• Citations: 28

Brugts JJ, Isaacs A, de Maat MPM, Boersma E, van Duijn CM, Akkerhuis KM, Uitterlinden AG, Witteman JCM, Cambien F, Ceconi C, Remme W, Bertrand M, Ninomiya T, Harrap S, Chalmers J, MacMahon S, Fox K, Ferrari R, Simoons ML, Danser AHJet al., 2011, A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals, JOURNAL OF HYPERTENSION, Vol: 29, Pages: 509-519, ISSN: 0263-6352

• Author Web Link
• Cite
• Citations: 38

Ceconi C, Freedman SB, Tardif JC, Hildebrandt P, McDonagh T, Gueret P, Parrinello G, Robertson M, Steg PG, Tendera M, Ford I, Fox K, Ferrari Ret al., 2011, Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL, INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol: 146, Pages: 408-414, ISSN: 0167-5273

• Author Web Link
• Cite
• Citations: 71

Winnik S, Raptis DA, Komajda M, Bax JJ, Tendera M, Fox K, De Werf FV, Luescher TF, Ruschitzka F, Matter CMet al., 2011, The peer review process of the ESC - impact on cardiovascular science in Europe, AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol: 183, Pages: 701-701, ISSN: 1073-449X

• Author Web Link
• Cite

de Silva R, Fox KM, 2010, PHARMACOTHERAPY Xanthine oxidase inhibition for relief of angina pectoris, NATURE REVIEWS CARDIOLOGY, Vol: 7, Pages: 603-604, ISSN: 1759-5002

• Author Web Link
• Cite
• Citations: 2

Van Vark LC, Brugts JJ, Akkerhuis KM, Oemrawsingh RM, De Maat M, Fox K, Ferrari R, Danser AHJ, Simoons ML, Boersma Het al., 2010, The NPPA gene in relation to blood pressure and response to ACE-inhibitor therapy: results of the PERindopril GENEtic association study, ESC Congress, Publisher: OXFORD UNIV PRESS, Pages: 531-532, ISSN: 0195-668X

• Author Web Link
• Cite

Brugts JJ, De Maat MPM, Ferrari R, Fox K, Macmahon S, Chalmers J, Bertrand M, Simoons ML, Danser AHJet al., 2010, RAAS polymorphisms in relation to hypertension and blood pressure lowering effect of ACE-inhibitors, ESC Congress, Publisher: OXFORD UNIV PRESS, Pages: 322-322, ISSN: 0195-668X

• Author Web Link
• Cite

Bell KJL, Hayen A, Macaskill P, Craig JC, Neal BC, Fox KM, Remme WJ, Asselbergs FW, van Gilst WH, MacMahon S, Remuzzi G, Ruggenenti P, Teo KK, Irwig Let al., 2010, Monitoring Initial Response to Angiotensin-Converting Enzyme Inhibitor-Based Regimens An Individual Patient Data Meta-Analysis From Randomized, Placebo-Controlled Trials, HYPERTENSION, Vol: 56, Pages: 533-U429, ISSN: 0194-911X

• Author Web Link
• Cite
• Citations: 22

Brugts JJ, De Maat MPM, Ferrari R, Fox K, Bertrand M, Remme W, Macmahon S, Chalmers J, Danser AHJ, Simoons MLet al., 2010, Genetic determinants of treatment benefit of ACE-inhibitor therapy in patients with stable coronary artery disease, ESC Congress, Publisher: OXFORD UNIV PRESS, Pages: 372-372, ISSN: 0195-668X

• Author Web Link
• Cite

Brugts JJ, Isaacs A, Boersma E, van Duijn CM, Uitterlinden AG, Remme W, Bertrand M, Ninomiya T, Ceconi C, Chalmers J, MacMahon S, Fox K, Ferrari R, Witteman JCM, Danser AHJ, Simoons ML, de Maat MPMet al., 2010, Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease, EUROPEAN HEART JOURNAL, Vol: 31, Pages: 1854-1864, ISSN: 0195-668X

• Author Web Link
• Cite
• Citations: 56

Fox K, 2010, Ivabradine: advantages throughout the cardiovascular continuum, Satellite Symposium on Ivabradine and comprehensive treatment of CAD, Publisher: OXFORD UNIV PRESS, Pages: C16-C20, ISSN: 1520-765X

• Author Web Link
• Cite
• Citations: 2

Bertrand ME, Ferrari R, Remme WJ, Simoons ML, Deckers JW, Fox KMet al., 2010, Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA study, AMERICAN HEART JOURNAL, Vol: 159, Pages: 795-802, ISSN: 0002-8703

• Author Web Link
• Cite
• Citations: 29

Daly CA, Clemens F, Lopez Sendon JL, Tavazzi L, Boersma E, Danchin N, Delahaye F, Gitt A, Julian D, Mulcahy D, Ruzyllo W, Thygesen K, Verheugt F, Fox KMet al., 2010, Inadequate control of heart rate in patients with stable angina: results from the European Heart Survey, POSTGRADUATE MEDICAL JOURNAL, Vol: 86, Pages: 212-217, ISSN: 0032-5473

• Author Web Link
• Cite
• Citations: 38

Gitt AK, Bueno H, Danchin N, Fox K, Hochadel M, Kearney P, Maggioni AP, Opolski G, Seabra-Gomes R, Weidinger Fet al., 2010, The role of cardiac registries in evidence-based medicine, EUROPEAN HEART JOURNAL, Vol: 31, Pages: 525-U9, ISSN: 0195-668X

• Author Web Link
• Cite
• Citations: 95

Lyne JC, Kilpatrick T, Duncan A, Knight CJ, Sigwart U, Fox KMet al., 2010, Long-Term Follow-Up of the First Patients to Undergo Transcatheter Alcohol Septal Ablation, CARDIOLOGY, Vol: 116, Pages: 168-173, ISSN: 0008-6312

• Author Web Link
• Cite
• Citations: 16

de Silva R, Fox KM, 2009, The changing horizon of acute coronary syndrome, LANCET, Vol: 374, Pages: 1125-1127, ISSN: 0140-6736

• Author Web Link
• Cite
• Citations: 1

Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferraris Ret al., 2009, Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial, EUROPEAN HEART JOURNAL, Vol: 30, Pages: 2337-2345, ISSN: 0195-668X

• Author Web Link
• Cite
• Citations: 172

Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Rothwell PM, Hennerici MG, Mattle HP, Kim JSet al., 2009, Rationale, design and patients' baseline characteristics of the PERFORM study, 19th World Congress of Neurology, Publisher: ELSEVIER SCIENCE BV, Pages: S69-S69, ISSN: 0022-510X

• Author Web Link
• Cite

Brugts J, Boersma E, Isaacs A, Remme W, Bertrand M, Fox K, Ferrari R, De Maat M, Danser A, Simoons MLet al., 2009, Identification of patients with impaired outcome on ACE-inhibitor therapy, EUROPEAN HEART JOURNAL, Vol: 30, Pages: 304-304, ISSN: 0195-668X

• Author Web Link
• Cite

Brugts J, Isaacs A, De Maat M, Van Duijn C, Remme W, Fox K, Ferrari R, Boersma E, Simoons ML, Danser AHJet al., 2009, Genetic determinants of blood pressure and blood pressure response to ACE-inhibitor therapy in patients with stable coroanry artery disease, EUROPEAN HEART JOURNAL, Vol: 30, Pages: 859-859, ISSN: 0195-668X

• Author Web Link
• Cite

Fox K, 2009, New results with ivabradine, EUROPEAN HEART JOURNAL SUPPLEMENTS, Vol: 11, Pages: D2-D7, ISSN: 1520-765X

• Author Web Link
• Cite

Brugts JJ, Ninomiya T, Boersma E, Remme WJ, Bertrand M, Ferrari R, Fox K, MacMahon S, Chalmers J, Simoons MLet al., 2009, The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials, EUROPEAN HEART JOURNAL, Vol: 30, Pages: 1385-1394, ISSN: 0195-668X

• Author Web Link
• Cite
• Citations: 54

de Silva R, Fox KM, 2009, ANGINA Ivabradine for treatment of stable angina pectoris, NATURE REVIEWS CARDIOLOGY, Vol: 6, Pages: 329-330, ISSN: 1759-5002

• Author Web Link
• Cite
• Citations: 10

Ceconi C, Fox KM, Remme WJ, Simoons ML, Deckers JW, Bertrand M, Parrinello G, Kluft C, Blann A, Cokkinos D, Ferrari Ret al., 2009, ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: Results from the PERTINENT study, ATHEROSCLEROSIS, Vol: 204, Pages: 273-275, ISSN: 0021-9150

• Author Web Link
• Cite
• Citations: 21

Remme WJ, Deckers JW, Fox KM, Ferrari R, Bertrand M, Simoons MLet al., 2009, Secondary Prevention of Coronary Disease with ACE Inhibition-does Blood Pressure Reduction with Perindopril Explain the Benefits in EUROPA?, CARDIOVASCULAR DRUGS AND THERAPY, Vol: 23, Pages: 161-170, ISSN: 0920-3206

• Author Web Link
• Cite
• Citations: 25

Brugts JJ, de Maat MPM, Boersma E, Witteman JCM, van Duijn C, Uitterlinden AG, Bertrand M, Remme W, Fox K, Ferrari R, Danser AHJ, Simoons MLet al., 2009, The Rationale and Design of the Perindopril Genetic Association Study (PERGENE): A Pharmacogenetic Analysis of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients with Stable Coronary Artery Disease, CARDIOVASCULAR DRUGS AND THERAPY, Vol: 23, Pages: 171-181, ISSN: 0920-3206

• Author Web Link
• Cite
• Citations: 22

Mihaylova B, Briggs A, Hlatky M, Armitage J, Parish S, Gray A, Collins Ret al., 2009, Statin Cost-Effectiveness in the United States for People at Different Vascular Risk Levels, CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, Vol: 2, Pages: 65-U26, ISSN: 1941-7705

• Author Web Link
• Cite
• Citations: 49

Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis Met al., 2009, ESC Guidelines on Management of Acute Myocardial Infarction in Patients Presenting With Persistent ST-Segment Elevation, REVISTA ESPANOLA DE CARDIOLOGIA, Vol: 62, Pages: 293-293, ISSN: 1885-5857

• Author Web Link
• Cite
• Citations: 72

Shurlock B, Fox K, 2009, To Me the Greatest Thing a Clinical Scientist Can Do Is to Add Even Just 1 Line to the Guidelines, CIRCULATION, Vol: 119, Pages: F25-F28, ISSN: 0009-7322

• Author Web Link
• Cite